TP53 and Alzheimer disease: In AD patients and AD-HHNs (human hippocampal neurons), the expression of NF-κB and miR-146a-5p (MicroRNAs) was increased, while the expression of TIGAR (TP53-induced glycolysis and apoptosis regulator) was significantly reduced.